BTI Q2 2026 Earnings Call Transcript
British American Tobacco (BTI) Q2 2026 earnings call reported 2.9% group revenue growth at constant currency and a 7.9% rise in adjusted diluted EPS. New Category revenue grew 18%, with Modern Oral up 66%. Smokeless was 19.8% of revenue. Full-year EPS guidance was upgraded to the mid of 5% to 8%, with GBP 1.3bn buyback for 2026 and Fit2Win savings of GBP 700m by 2028.
How this was made

The 30-second read
Why it matters
Traders can update models for BTI based on the upgraded full-year EPS range, revised net finance cost expectations, and explicit capital return and leverage targets.
Market read
The transcript provides concrete guidance and balance-sheet/capital allocation updates that can drive near-term repricing of BTI’s earnings outlook.
What to watch
Fit2Win transformation includes one-off costs (GBP 950M) and manufacturing asset upgrade charges (GBP 230M non-cash), which could complicate near-term cash flow quality versus headline EPS.
Background
BTI management discusses progress on its Fit2Win transformation, smokeless growth, and regional performance during the Q2 2026 earnings call transcript.
Ticker impact
British American Tobacco upgraded full-year EPS guidance to the middle of a 5% to 8% range, citing lower net finance costs and cash conversion.
Moderate upside bias into the next trading sessions as traders price in improved EPS outlook and lower finance-cost drag.
The transcript includes specific, decision-relevant updates: upgraded EPS range, expected net finance costs of about GBP 1.65B, and a 2026 buyback allocation of GBP 1.3B with a stated leverage target.
Market effects
Reinforces the market narrative that smokeless and modern oral categories are gaining share, while heated products face competitive pressure in value segments.
Highlights APMEA headwinds tied to regulation and illicit volume, versus relative resilience in AME and improving U.S. legal vapour enforcement.
Supports broader tobacco sector expectations for margin expansion from transformation programs and debt repayment-driven finance-cost relief.
Counterpoint
The guidance upgrade may be partially offset by ongoing heated-product declines and APMEA regulatory/illicit-volume uncertainty, limiting how durable the margin expansion is.
Key entities
- companyBritish American Tobacco p.l.c.
Subject of the earnings call transcript, providing guidance upgrades, segment performance updates, and capital allocation details.
- executiveTadeu Marroco
CEO who highlighted U.S. vapour enforcement-driven legal market growth and upcoming Velo Max launch.
- executiveJaved Iqbal
Interim CFO who discussed financial performance drivers including lower net finance costs and transformation savings.
